Barrington Strategic Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Barrington Strategic Wealth Management Group's BMY Position: Q3 2017 in Review
Barrington Strategic Wealth Management Group reduced its Bristol-Myers Squibb (BMY) stake by 3.3% in Q3 2017, selling an estimated $31K and leaving 15,428 shares worth $983K. The position accounts for 0.5% of the portfolio, ranked #54.
Barrington Strategic Wealth Management Group first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.27M in Q2 2016. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.
- Barrington Strategic Wealth Management Group held 15,428 shares of Bristol-Myers Squibb worth $983K as of Q3 2017.
- Barrington Strategic Wealth Management Group sold 531 Bristol-Myers Squibb shares in Q3 2017, an estimated $31K.
- Bristol-Myers Squibb made up 0.5% of Barrington Strategic Wealth Management Group's portfolio in Q3 2017, its #54 holding.
- Barrington Strategic Wealth Management Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
- Barrington Strategic Wealth Management Group's Bristol-Myers Squibb position peaked at $1.27M in Q2 2016.
- 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.
Based on Barrington Strategic Wealth Management Group's 13F filing for Q3 2017, filed 31 Oct 2017.